Narcolepsy is now treated symptomatically using monoaminergic amphetamine-like and antidepressant compounds 35. These compounds have many untoward side effects and only partially control the ...

By some estimates, nearly half of the world's population suffers from a sleep disorder of some kind. Whether it be sleep ...

The main growth driver for Alkermes going forward will be ALKS 2680. Read why I maintain my buy rating on ALKS stock.

People with narcolepsy are also more likely to have ADHD. One study found that as many as 30% of people with type 1 narcolepsy (the kind that includes cataplexy, sudden attacks of muscle weakness ...

Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information ...

Some people with narcolepsy may be able to drive safely, especially if they drive when well-rested and stick to short trips. Most people with narcolepsy can legally drive in the United States.

For children living with narcolepsy, school can feel like a real challenge. But there are steps you can take to set up your child for a productive and successful year. It’s key to enlist the sup ...

An expert discusses treatments for narcolepsy, comparing options for managing excessive daytime sleepiness (EDS) and cataplexy, and examines the advantages, limitations, and clinical scenarios for ...

An expert discusses the significance of low-sodium oxybate for patients with narcolepsy patients with and cardiovascular disease and compares the diagnostic criteria and clinical presentations of ...

has announced promising preclinical results for its drug AEX-2, a non-sulfonamide dual orexin receptor agonist (DOXA), aimed at treating narcolepsy and related neurological disorders. The company ...

NLS Pharmaceutics (NLSP) announces new preclinical findings on AEX-2, reinforcing its potential as a first-in-class non-sulfonamide dual orexin ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...